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B7-2 (Leach et al., 1996). Conversely, inhibition of B7/and Simon J. Davis²§
CD28 interactions results in general immunosuppres-*Division of Structural Biology
sion (Linsley et al., 1992b), reduced autoantibody pro-Wellcome Trust Centre for Human Genetics
duction (Finck et al., 1994), and enhanced skin and car-The University of Oxford
diac allograft survival (Larsen et al., 1996). There is,Roosevelt Drive
therefore, considerable interest in the therapeutic po-Oxford OX3 7BN
tential of manipulating human B7 interactions, and suchUnited Kingdom
approaches have already shown promise (Guinan et al.,²Nuffield Department of Clinical Medicine
1999).The University of Oxford
B7-1 and B7-2 each consist of single V-like and C-likeJohn Radcliffe Hospital
immunoglobulin superfamily (IgSF) domains (FreemanHeadington, Oxford OX3 9DU
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V-like IgSF domains (Aruffo and Seed, 1987; Brunet etNew Chemistry Laboratory
al., 1987). A third CD28-like molecule, ICOS (Hutloff etSouth Parks Road
al., 1999), interacts with another B7-related moleculeOxford OX1 3QT
(D. Brodie et al., unpublished data), but the analysis ofUnited Kingdom
transgenic mice indicates that B7-1 and B7-2 are the
only functional ligands of CD28 and CTLA-4 (Mandelbrot
et al., 1999). The affinities of these interactions differSummary
substantially: human CTLA-4 binds B7-1 with a solution
Kd of 0.2±0.4 mM (van der Merwe et al., 1997), whereasB7-1 (CD80) and B7-2 (CD86) are glycoproteins ex-
the affinity of CD28 for B7-2 is 40- to 100-fold lowerpressed on antigen-presenting cells. The binding of
(B7-1/CD28 and B7-2/CTLA-4 interactions each havethese molecules to the T cell homodimers CD28 and
intermediate affinities [Kd 5 4 mM]; A. V. C. et al., unpub-CTLA-4 (CD152) generates costimulatory and inhibi-
lished data).tory signals in T cells, respectively. The crystal struc-
The expression of B7-1, B7-2, CD28, and CTLA-4 isture of the extracellular region of B7-1 (sB7-1), solved
tightly regulated: whereas CD28 is constitutively ex-to 3 AÊ resolution, consists of a novel combination of
pressed on resting human T cells and B7-2 is rapidlytwo Ig-like domains, one characteristic of adhesion
induced on antigen-presenting cells early in immunemolecules and the other previously seen only in anti-
responses, the expression of both B7-1 and CTLA-4gen receptors. In the crystal lattice, sB7-1 unexpect-
is considerably delayed (reviewed by Lenschow et al.,edly forms parallel, 2-fold rotationally symmetric ho-
1996). Interactions of the B7 molecules with CD28 gener-modimers. Analytical ultracentrifugation reveals that
ate costimulatory signals amplifying T cell receptorsB7-1 also dimerizes in solution. The structural data
(TCR) signaling and preventing anergy, whereas interac-suggest a mechanism whereby the avidity-enhanced
tions with CTLA-4 induce powerful inhibitory signals inbinding of B7-1 and CTLA-4 homodimers, along with
T cells (Martin et al., 1986; Weiss et al., 1986; Harding
the relatively high affinity of these interactions, favors
et al., 1992; Walunas et al., 1994; Waterhouse et al.,
the formation of very stable inhibitory signaling com- 1995). CD28-dependent costimulation is poorly under-
plexes. stood, but recent work implicates the bulk recruitment
of cell surface molecules and kinase-rich rafts to the site
Introduction of TCR engagement, favoring receptor phosphorylation
and signaling (Viola et al., 1999; WuÈ lfing and Davis,
The course of an immune response is in large part con- 1999). Conversely, CTLA-4 inhibits signal transduction
trolled by the interactions of leukocyte cell surface mole- by recruiting the tyrosine phosphatase SHP-2 to the
cules. Among the most important are those involving TCR, resulting in dephosphorylation of the z chain of the
the B7 molecules B7-1(CD80) and B7-2(CD86), which complex and components of the RAS signaling pathway
are expressed on antigen-presenting cells and bind to (Marengere et al., 1996; Lee et al., 1999), and by interfer-
both CD28 and CTLA-4(CD152) expressed on T cells ing with distal events in the CD28 signaling pathway
(reviewed by Lenschow et al., 1996; Greenfield et al., (Olsson et al., 1999).
1998). Altering these interactions has profound effects While the opposing effects of CD28 and CTLA-4 are
on immune responses in experimental disease models. clear cut, distinct functions for B7-1 and B7-2 have yet
Enhanced anti-tumor immune responses result from to be defined. A role in TH0, TH1, or TH2 differentiation
has been proposed (Freeman et al. 1995; Kuchroo et
al., 1995), but other work (Schweitzer et al., 1997) sug-§ To whom correspondence should be addressed (e-mail: david.
stuart@strubi.ox.ac.uk and sdavis@molbiol.ox.ac.uk). gests that B7-1 and B7-2 determine the magnitude of
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costimulatory signals rather than the outcome of TH
subset differentiation (reviewed by McAdam et al., 1998).
Supporting this view, quantitative rather than qualitative
effects on tyrosine phosphorylation follow the stimula-
tion of T cells with artificial antigen-presenting cells ex-
pressing B7-1 or B7-2 (Slavik et al., 1999). Moreover,
gene disruption studies reveal considerable overlap in
the costimulatory functions of B7-1 and B7-2 (Freeman
et al., 1993b; Borriello et al., 1997). A third possibility is
that, rather than having distinct CD28-dependent costim-
ulatory roles, the key functional differences concern the
strength and/or mode of binding of B7-2 and B7-1 to
CD28 and CTLA-4.
We have determined the crystal structure of a soluble
(s) form of human B7-1 at 3 AÊ resolution. The structure
of the sB7-1 monomer combines features of both the
adhesion and antigen receptor subgroups of the IgSF.
The arrangement of sB7-1 monomers in the crystal
lattice implies that sB7-1 might spontaneously form
homodimers, an observation we confirm using analytical
ultracentrifugation. These results have important impli-
cations regarding the structure and properties of the
signaling complexes B7-1 will form in the contact zones
between antigen-presenting cells and T cells.
Results
Structure Determination
A histidine-tagged, selenomethionine (SeMet)-labeled
form of sB7-1 consisting of residues 1±201 of the mature
polypeptide (van der Merwe et al., 1997) was expressed
in the Chinese hamster±derived, Lec3.2.8.1 cell line in
the presence of 0.5 mM N-butyl deoxynojirimycin and
then deglycosylated as described (Butters et al., 1999).
Deglycosylated, unlabeled sB7-1 bound CTLA-4 with
wild-type affinity (A. V. C. et al., unpublished data). After
removal of the histidine tag, crystals of space group
I4122 that diffracted to 3 AÊ resolution at a synchrotron
source (BM14 of the European Synchrotron Radiation
Figure 1. The Structure of the SeMet Form of sB7-1Facility [ESRF], Grenoble, France) were obtained. The
(A) Two orthogonal views, shown in ribbon format, of the sB7-1structure was determined using the multiple-wavelength
monomer. To indicate the course of the main chain, the color isanomalous dispersion (MAD) method.
varied from blue for residue 1 to red for residue 200. Asparagine
residues that are part of glycosylation sequons are colored green
and modeled with N-acetylglucosamine residues where electronOverall Structure
density was sufficiently clear.The sB7-1 monomer is a slender molecule, with dimen-
(B) Schematic a carbon representations of sB7-1, CD4d1d2 (1cdy),sions of 23 3 30 3 90 AÊ 3, consisting of two anti-parallel
human sCD2 (1hnf), and IgG1 l light chain (8fab) are shown superim-
b sandwich IgSF domains joined by a short linker region posed on domain 2 of each molecule.
(Figure 1A). Thr-199 forms the last main chain hydrogen (C) Comparisons of the V-set IgSF domains of B7-1, human CD2
and IgG1 l light chain.bond in the molecule and Ala-200 is well ordered but
(D) Two orthogonal views of domain 2 of B7-1 superimposed on theextends into solution. Between this residue and the
equivalent domains of IgG1 l light chain and hCD2. The C9 or Dprobable first residue of the transmembrane domain
strands are highlighted.(Leu-209), the native protein sequence consists of eight,
(E) The interdomain region of B7-1 with domain 1 and 2 colored red
mostly hydrophilic, residues likely to form an extended and green, respectively. The network of residues mediating interdo-
stalk linking the protein to the cell surface. Overall, the main contacts are shown in ball-and-stick representation.
organization and dimensions of sB7-1 resemble those
of the extracellular region of CD2 (Figure 1B), although
there is a significant change in relative domain orienta- comparisons (DALI; Holm and Sander, 1995) rank B7-
tion (see below). 1d1 as most similar to the membrane distal domains of
CD2 (1hnf) and CD4 (1cdy), molecules involved in cell±
cell adhesion. Superimpositions of the B7-1, CD2, andImmunoglobulin-like Domains
The amino-terminal domain (d1) of B7-1 has V-set topol- antibody (IgVLl) V-set domains are shown in Figure 1C
(rms differences between B7-1d1 and CD2d1 and theogy (Williams and Barclay, 1988), with b strands forming
DEB and AGFCC9C99 b sheets. Automated structure Ig domain are 1.1 AÊ and 1.3 AÊ for 89 and 81 equivalent Ca
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Figure 2. Alignment of B7 Subset and Human CD2 d1 and IgCLl Sequences Based on the sB7-1, sCD2, and IgG1 l Light Chain Crystal
Structures
The B7 subset, initially defined by Linsley et al. (1994), is extended to include chicken CD80-like protein (chCD80L; TrEMBL accession number
O42404). Alignments were done using CLUSTALW (Thompson et al., 1994) and then adjusted by eye. The structural alignments of B7-1 d1
and d2 with CD2 d1 and IgCLl, respectively, are based on the superpositions shown in Figure 1. Residues that are structurally equivalent in
the superpositions are highlighted with yellow bars. Open and closed blue bars above the sequences mark a helices and b strands in the
sB7-1 structure, respectively. Buried residues (i.e., those exposing less than 25 AÊ 2 of side chain surface area) are highlighted with red bars.
Amino acids that exhibit a high degree of conservation in V and C1-set IgSF domains (Barclay et al., 1997) are colored blue, whereas those
shaded orange are conserved only within the B7 subset sequences.
atoms, respectively). An important structural similarity membrane-proximal domains, the position of the mem-
brane-distal (N-terminal) domain of sB7-1 differs fromshared by B7-1d1 and CD2d1, distinguishing these do-
that of sCD2 by a rotation of 1008 about the long axismains from antigen receptor V-set domains, is the lack
of the molecule and a reduction of 208 in tilt relative toof overall twist in the AGFCC9C99 sheet. This reflects the
the same axis. The rotation occurs about Ala-106 of B7-1fact that B7-1d1 has its b bulges located immediately
(Glu-104 in CD2). The reduced tilt, and the much longerafter the CC9 and FG turns at residues Met-38 and Arg-
D and E strands of d2, result in the interdomain region94, (equivalently positioned at residues Lys-43 and Asn-
of B7-1 burying a larger surface area (670 versus 590 AÊ 2)92 in human CD2d1; Bodian et al., 1994) rather than the
than is the case for CD2. This region consists of a buried,C9 and G strand b bulges conserved in antigen receptor
hydrophobic core formed by Val-8, Pro-74, Ala-106,V-set domains.
Phe-134, and Leu-163. In addition, electrostatic con-In contrast to d1, the membrane proximal domain
tacts and main chain or side chain hydrogen bondsof B7-1 (d2) exhibits greater similarity to the constant
between Ser-75 and Glu-162, and between Arg-73 anddomains of antigen receptors and the membrane proxi-
both Pro-159 and Glu-160, appear to stabilize the ex-mal domains of MHC antigen-type structures than to
tended, upright stature of the extracellular region ofthe membrane proximal domain of cell±cell adhesion
B7-1. The elaborate network of interactions supportingmolecules. The d2 b sandwich is formed by DEBA and
d1 is shown in Figure 1E.GFC b sheets typical of C1-set domains (Williams and
The distinctive features of B7-1 define a new subsetBarclay, 1988). Thus, the six structures most similar to
of the IgSF, into which sequence analysis groups B7-2,B7-1d2 selected by DALI all contain C1-set domains,
a chicken CD80-like protein (chCD80L), myelin/oligo-and structural superposition of B7-1d2 with the constant
dendrocyte (hMOG) protein, the milk-fat globule mem-domain of immunoglobulin l light chain reveals greater
brane protein, butyrophilin (hbut), and the chicken MHCsimilarity than the superposition of B7-1d2 with CD2d2
molecule, B-G antigen (chBG; Figure 2; Linsley et al.,(rms differences of 1.4 AÊ and 1.5 AÊ for 80 and 64 equiva-
1994; O'Regan et al., 1999). Although low, sequencelent residues, respectively; Figure 1D). The key structural
identities indicate that these molecules have similar sec-feature is the organization of the strands at the ªedgeº
ondary and tertiary structures. The largest block of con-of the domain: whereas beyond the C strand, CD2 has
served residues that are not IgSF consensus residuestwo short C9D strands extending the same b sheet, the
lie in the D and E b strands and DE loop of domain 2.B7-1 and the Fab C1-set domains have extended DE
The conservation of this region, which is involved in thestrands forming the first half of the second b sheet.
key interdomain electrostatic contacts, along with the
conserved hydrophobicity of the interdomain core (resi-
Interdomain Region dues 8, 106, 134, and 163), suggests that the frameworks
The interdomain ªlinkersº of B7-1 and human CD2 are of these molecules are likely to be similar.
identical in length (seven residues) and share remarkably
similar main chain conformations, even though only Pro- Ligand Binding
111 and Ile-113 are conserved in both sequences (B7-1 Substantial losses (.90%) in ligand-binding activity oc-
cur when the solvent-exposed residues Arg-29, Tyr-31,sequence numbering). After superimposition of the
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residues may explain the cross-reactivities of human
and mouse B7-1 and B7-2 with human and mouse CD28
and CTLA-4.
It has been proposed that d2 residues form part of
the B7-1 ligand-binding site (Peach et al., 1995). How-
ever, the relevant mutations (of DE loop residues Gln-
157, Asp-158, and Glu-162) have much weaker effects
on ligand binding (,50% inhibition) than mutations of
the d1 AGFCC9C99 face and inspection of the structure
suggests that such effects could result from changes
in the presentation of d1 via alterations in the network of
interactions at the domain interface (Figure 1E). Simple
modeling also indicates that CTLA-4 cannot simultane-
ously bind both sets of residues. Furthermore, direct
involvement of d2 would generate B7-1/ligand com-
plexes spanning a much shorter intermembrane dis-
tance (z10 nm) than TCR/MHC complexes (z15 nm),
creating a steric barrier to the CTLA-4/TCR interactions
required for inhibitory signaling by CTLA-4 (Lee et al.,
1999). For these reasons, we conclude that the d1
AGFCC9C99 face represents the principal ligand-binding
surface of B7-1.
The AGFCC9C99 face of B7-1 is compositionally similar
to other sites of protein±protein recognition and thus
has substantially fewer charged and more hydrophobic
residues than the equivalent face of CD2, which is also
involved in low-affinity cell surface recognition (29%
charged residues versus 45%±70% for CD2 [Bodian et
al., 1994; Davis et al., 1998a]). Surface electrostatic po-
tential is depicted in Figure 3B. Two hydrophobic resi-
dues essential for ligand binding, Met-38 and Trp-50,
form a contiguous hydrophobic patch at the base of the
AGFCC9C99 sheet of d1. In a complementary manner,Figure 3. Properties of the Ligand Binding Faces of B7-1d1 and
the conserved MYPPPY sequence motif implicated inCTLA-4, and a Modeled Complex of these Molecules
the binding of both CTLA-4 and CD28 to B7-1 and B7-2In (A) (B7-1d1) and (D) (CTLA-4), the GRASP surfaces of residues
whose mutation to alanine disrupts or has no effect on binding (Figure 3D; Metzler et al., 1997), forms a hydrophobic
(Peach et al., 1995; Metzler et al., 1997) are colored magenta and patch centered on the FG loop of CTLA-4. The distribu-
cyan, respectively. In (B) and (E), the electrostatic potential calcu- tion of hydrophobicity on the surfaces of the AGFCC9C99
lated at neutral pH is shown projected onto the GRASP surfaces of face of each molecule is shown in Figures 3C and 3F.
each molecule; blue represents positive potential, white represents
Manual docking of B7-1 d1 and CTLA-4, so that con-neutral, and red represents negative potential contoured at 6 8.5 kT.
tact between the two hydrophobic patches and electro-In (C) and (F), hydrophobicities calculated using GRID (P. Goodford,
personal communication) are projected onto the GRASP surfaces of static complementarity are each maximized, and in a
each molecule; yellow highlights regions of greatest hydrophobicity. way that would permit interactions between adjacent
The line of view in each panel is essentially perpendicular to the cells, readily generates a feasible model for the complex
AGFCC9C99 ligand binding face of each molecule. In (G), the MYPPPY of these two molecules (Figure 3G). The model is remi-
sequence of CTLA-4 implicated in B7-1 binding is highlighted as a
niscent of the antiparallel homophilic contacts observeddarker blue loop in these two orthogonal views of the modeled
in crystals of Protein 0 (Shapiro et al., 1996) and buriescomplex.
approximately 800 AÊ 2 of surface area per molecule, an
area comparable to that buried in most other protein
complexes (Janin and Chothia, 1990). The exaggeratedGln-33, Met-38, Ile-49, Trp-50, and Lys-86 of B7-1
twist of the AGFCC9C99 b sheet of CTLA-4 could alloware substituted with alanine (Figure 3A; Peach et al.,
extensive contact with the very long FG loop of B7-1,1995). With the exception of Lys-86, these residues form
which appears to be a conserved feature of the B7-a contiguous, L-shaped cluster identifying the d1
related sequences (Figure 2).AGFCC9C99 face as the ligand binding site of B7-1. Lys-
86, which is not in the AGFCC9C99 face, may nevertheless
form a salt bridge with Glu-24 in the BC loop that stabi- Molecular Association in the Crystal
A striking and unexpected feature of the sB7-1 crystallizes the conformation of the FG loop. Not all of the
residues surrounding this patch have been mutated, lattice is that it is dominated by a molecular contact at
the 2-fold axis, which buries 610 AÊ 2 of surface area forhowever, and it is likely that the full binding surface
is substantially larger than this. Gln-33 is completely each molecule. The lattice contact generates a compact
dimer that, in overall shape and dimensions, is reminis-conserved in human and mouse B7-1 and B7-2, as are
aromatic residues at position 31 and hydrophobic resi- cent of an antibody Fab9 molecule (Figure 4A). However,
the dimer differs from a Fab9 insofar as the d1 interactiondues at position 38 (Figure 2). The conservation of these
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Figure 4. Structure of the sB7-1 Homodimer Observed in the Crystal Lattice
(A) Two orthogonal views of the GRASP surface of the homodimer showing the location of residues whose mutation to alanine disrupts
(magenta) or has no effect (cyan) on binding. Putative N-glycosylation sites are colored green.
(B) The GRASP surfaces of amino acids involved in forming the dimer are colored red. The view is identical to the right-hand panel in (A) but
with the front copy of sB7-1 removed.
(C) Details of the residues at the dimer interface are shown in ball-and-stick format viewed as in the left-hand panel of (A).
(D) The homodimer is shown with either oligomannose, bi-, or triantennary N-glycans modeled at each of the potential glycosylation sites.
is mediated by a relatively flat surface formed by the B, Experimental Procedures) indicates that sB7-1 under-
goes dimerization in solution with a Kd in the range ofC99, D, and E b strands rather than the AGFCC9C99 face,
and there is no contact between d2 of each molecule 20±50 mM. At higher concentrations, aggregation also
occurred (data not shown). These effects are reversible,(although such contacts might be possible in vivo and
may only be precluded by this particular lattice). The and sedimentation velocity boundary analysis (Stafford,
1992) of samples in a concentration range where bothinteraction is mediated by the primarily hydrophobic
residues (Val-11, Val-22, Gly-45, Met-47, Ile-58, Asp-60, monomer and dimer were present was unable to differ-
entiate between the species, indicating that monomerIle-61, Thr-62, and Leu-70) decorating the B, C99, D, and
E b strands, leaving the AGFCC9C99 face free for ligand and dimer are in rapid exchange with a rate constant
of dissociation greater than 1022 s21 (Cann, 1986). Thebinding (Figures 4B and 4C). The molecules are inclined
by 48 to the 2-fold axis, an arrangement consistent with temperature dependence of the Kd is consistent with
the largely hydrophobic nature of the contact seen inthe C-terminal stalks linking the molecules to the cell
surface entering the membrane adjacently. The distribu- the crystal lattice.
tion of the glycosylation sites on the sB7-1 structure
indicates that, even if all potential sites were to be fully Discussion
utilized, the dimer interface would be free of N-linked
glycans (Figures 4A and 4D). The relationship of the structure of the extracellular re-
gion of B7-1 to its function is illuminated by comparison
with CD2. A key structural difference between B7-1 andDimerization of sB7-1 in Solution
Analytical ultracentrifugation at a range of concentra- CD2 lies in d2 of each molecule. In B7-1 this domain
is topologically similar to C1-set domains, which havetions and at three temperatures (Figures 5A and 5B; see
Figure 5. Analytical Ultracentrifugation of
sB7-1
Apparent whole-cell weight-average molecu-
lar weight (Mw,app) of sB7-1 as a function of
sample loading concentration at 48C (closed
circles) and 208C (open circles) (A) and at 378C
(open circles) (B). The 48C (dashed line, [A]),
208C (solid line, [A]), and 378C (solid line, [B])
data have been fitted to equation 2 to obtain
apparent dissociation constants. The trends
in Mw,app indicate that sB7-1 is undergoing
self-association and is in dynamic equilibrium
between a monomeric form (Mw,app z 27 kDa)
and a dimeric form (Mw,app z54 kDa). The pa-
rameters given by the fits to the data for sB7-1
are a monomer mass (M1) of 26609 6 2206
Da, with a dissociation constant Kd of 44 mM
at 48C; an M1 of 27384 6 1942 Da, Kd of 33
mM at 208C; and an M1 of 27478 6 3176 Da,
with a dissociation constant Kd of 17 mM
at 378C.
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the C1-set are adhesion molecules, and antigen recep-
tors essential for adaptive immune responses (charac-
terized by GFCC9C99 b sheet mediated V-set heterodi-
merization [Springer, 1991]) appear late in the evolution
of the IgSF (Figure 6). Similarity between domain 2 of
B7-1 and the C1-set domain of b2-microglobulin was
predicted by Bajorath et al. (1994), and the genetic link-
age of B7-related molecules to the MHC has been noted
previously (Henry et al., 1997).
Although sB7-1 and sCD2 have similar overall dimen-
sions, the reduced tilt of domain 1 relative to domain 2
positions the ligand binding AGFCC9C99 face of B7-1
normal to the long axis of the molecule rather than, as
in CD2, parallel with it (Jones et al., 1992; Bodian et al.,
1994). Such differences may be related to the sequence
Figure 6. Evolutionary Relationships of the IgSF Constant-like of expression of these genes. Maximum exposure of the
Domains ligand binding face at the ªtopº of the molecule may be
The parts of the lineage colored blue are proposed to have gener- crucial for establishing the initial contact zone between
ated cell adhesion and cell±cell recognition molecules, whereas the T cells and antigen-presenting cells by CD2 (van der
red section produced components of the adaptive immune re-
Merwe et al., 1995; Davis and van der Merwe, 1996;sponse. CD2 is used to represent the C2/I-set.
Dustin et al., 1998). B7-1 appears after formation of
the contact zone, however, when the interacting cell
surfaces are already optimally aligned for interactions
previously only been observed in the structures of anti- involving molecules the size of B7-1, the T cell receptor,
gen receptors and MHC antigens; in contrast, CD2d2 and their respective ligands. An important consequence
belongs to the C2-set. The ALIGN program (Dayhoff et of the essentially parallel alignment of d1 and d2 of B7-1
al., 1983) gives significantly higher scores for compari- is that it exposes the non-ligand-binding DEB face of d1,
sons of human and mouse B7-1d2 sequences with rep- allowing the formation of parallel, compact homodimers.
resentative C1-set sequences (Barclay et al., 1997) than The formation of equivalent dimers by CD2 is precluded
for C2-set sequences (5.4 6 0.56 versus 2.79 6 1.99, by the 428 tilt in the position of d1 relative to the long
respectively). Thus, both topology and sequence place axis of the molecule (Jones et al., 1992; Bodian et al.,
d2 of B7-1 within the C1-set. However, the ALIGN scores 1994).
for B7-1d2 comparisons with other C1-set sequences Functionally distinct interactions are suggested by the
are significantly lower than for comparisons within the presence of radically different molecular contacts in the
classic C1-set (8.5 6 2.7). This implies that the appear- crystal lattices of sB7-1 and sCD2. sCD2 packs head-
ance of B7-1-like molecules may have predated the evo- to-head, an arrangement which was predicted (Jones
lution of distinct antigen receptors and MHC antigens. et al., 1992) and subsequently shown (Wang et al., 1999)
B7-1 and B7-2, while clearly related, share very limited to mimic natural receptor-ligand interactions. In con-
sequence similarity, and human and mouse B7-2d2 give trast, the sB7-1 crystal lattice is dominated by a side±
equally poor matches with both C1- and C2-set se- side molecular contact that generates a potentially biva-
quences (2.3 6 0.9 and 2.2 6 1.1), suggesting that B7-2 lent homodimer. Model studies indicate that cell surface
might be even more primitive. Taken with the observa- proteins with solution affinities in the range of 15±75 mM
tion that the adhesion domains of B7-1 and CD2 are interact spontaneously at membrane interfaces (Dustin
remarkably similar, these data suggest a set of evolu- et al. 1996; 1997). The Kd of 20±50 mM for dimerization
and rapid monomer±dimer exchange we have observedtionary relationships in which the earliest members of
Figure 7. Potential Molecular Complexes
Formed by the B7-1 and CTLA-4 Homodimers
at the Cell Surface
The B7-1 homodimer shown is identical to
that observed in the crystal lattice. The CTLA-4
homodimer is based on the solution structure
of the monomer (Metzler et al., 1997), with
the sequence connecting b strand G to the
intermolecular disulphide at Cys-123 mod-
eled in extended conformation. The ligand-
binding domains of B7-1 and CTLA-4 are
docked as described in the text, allowing the
formation of two potential types of com-
plexes: paired homodimers (A) and com-
plexes in which separate sB7-1 homodimers
are bridged by adjacent CTLA-4 dimers (B).
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Table 1. Data Collection and Refinement Statistics
Data Processing
Wavelength (AÊ ) 0.8855 0.9793 0.9796 all
Observation 34,375 34,531 36,114 105,456
Unique* 9,341 9,349 9,436 5,409
Redundancy 3.7 3.7 3.8 19.5
,I/s(I). 12 (3) 10 (2) 11 (2) 24 (5)
Rmerge (%) 9.2 (42) 9.3 (43) 9.2 (42) 11.4 (48)
Resolution (AÊ ) 20±3.0 (3.1±3.0)
Completeness (%) 98 (93) 99 (96) 99 (93) 100 (99)
Refinement
Data range (AÊ ) 20±3.0 (3.1±3.0)
Reflections (F.0) 5,204 (283)
Completeness (%) 96.5 (88.9)
Reflections in Rfree set 289 (21)
Nonhydrogen atoms (protein/sugar) 1,604/42
Rms D bond lengths (AÊ ) 0.008
Rms D bond angles (8) 1.4
Rms D B factors for bonded atoms (AÊ 2) (main/side) 1.3/1.9
Mean B factors (AÊ 2) (main/side/sugar) 41.4/42.8/49.0
Mean main chain B factors (AÊ 2) (domain 1/domain 2) 45.2/37.2
Rfree (%) 28.2 (35.4)
Rcryst (%) 23.7 (34.1)
* For data sets collected at individual wavelengths, Bijvoet pairs were not merged. However, the Bijvoet pairs were merged in the data set
generated by merging the data collected at all wavelengths.
Values in parentheses correspond to the highest resolution shell (3.1±3.0 AÊ ).
Rmerge 5 SjI 2 ,I.j/S,I.
Rcryst 5 SjjFobsj 2 jFcalcjj/SjFobsj
Rfree 5 as for Rcryst but calculated for a test set comprising reflections not used in the refinement.
Root mean squared deviations (rms D) in bond length and angles are given from ideal values.
suggests that B7-1 may exist at the cell surface in a structural considerations, along with the timing of B7-1
and CTLA-4 expression, suggest that a key function ofdynamic equilibrium dominated by a homodimer similar
to that observed in the crystal. Since CTLA-4 exists as B7-1 is to generate particularly stable signaling com-
plexes with CTLA-4 late in immune responses, increas-a disulfide-bonded homodimer, the existence of B7-1
dimers would allow two types of multivalent associa- ing the likelihood of inhibitory signaling by CTLA-4 and
facilitating the termination of T cell activation.tions to form at the cell±cell interface, one involving
paired homodimers (Figure 7A), the alternative involving
Experimental Proceduresa dimer of B7-1 bridging adjacent CTLA-4 dimers (Figure
7B). Simple modeling studies suggest that the second
Protein Expression and Crystallizationtype of interaction might be sterically favored.
The expression of a construct encoding a histidine-tagged form of
CTLA-4 is not expressed on resting T cells, and the sB7-1, consisting of residues 1±201 of the native protein and bearing
level of CTLA-4 expression at the cell surface is kept a deleted C-terminal glycosylation site (Asn-198), in Lec3.2.8.1 cells
very low, even on activated cells (Linsley et al., 1992a). in the presence of 0.5 mM N-butyl deoxynojirimycin is described
by Butters et al. (1999). SeMet labeling was done according to theCTLA-4 is also stored in intracellular vesicles (Leung et
method of May et al. (1997). After removal of the histidine tag withal., 1995) whose release is directed at the contact zone
carboxypeptidase A (van der Merwe et al., 1997), data collection±between activated T cells and antigen-presenting cells
quality wild-type and SeMet sB7-1 crystals grew readily in sitting
(Linsley et al., 1996). This suggests that its release into drops containing 2 ml of protein (at an optical density of 20±30 in
and sequestration within the central supramolecular ac- 10 mM HEPES, 140 mM NaCl, 0.05% NaN3 [pH 7.4]) and 2 ml of
tivation cluster (cSMAC) of the immunological synapse reservoir solution (typically a 10%±90% v/v dilution of a stock solu-
tion containing 28% PEG 400, 0.1M Na HEPES (pH 7.5), 0.2M CaCl2).(Monks et al., 1998; Grakoui et al., 1999) is key to the
inhibitory function of CTLA-4. The solution affinity of
Structure DeterminationB7-1 for CTLA-4 (z0.2±0.4 mM) is among the highest
The crystals belong to space group I4122 (cell dimensions a 5 b 5described for interacting cell surface molecules (re-
57.3 AÊ , c 5 298.9 AÊ , consistent with a single molecule per asymmet-
viewed in Davis et al., 1998b), at least 10-fold higher ric unit). For data collection at 100 K, crystals were briefly transferred
than the affinity of B7-1/CD28 interactions (z4 mM; van to mother liquor containing 10% v/v glycerol. Molecular replacement
and multiple isomorphous replacement phasing attempts failedder Merwe et al., 1997) and 40- to 100-fold higher than
(high levels of nonisomorphism were apparent between native andthat of B7-2/CD28 interactions (z15 mM; A. V. C. et al.,
heavy atom data sets). Diffraction data for MAD-based phase deter-unpublished data). The avidity model proposed in Figure
mination were collected from one cryo-cooled SeMet sB7-1 crystal7B would provide a mechanism for further stabilizing
at station BM14 of the ESRF. The Se absorption edge was located
the interaction of B7-1 with CTLA-4 within the cSMAC. by a fluorescence scan, and consecutive data sets were collected
While it is clear that B7-1/CD28 interactions may gener- at three wavelengths (l 5 0.8855 AÊ , 0.97930 AÊ , and 0.97955 AÊ , the
latter wavelengths being at the white line and inflection point) usingate competing costimulatory signals, the foregoing
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the 180 mm scan mode of a 345 mm diameter MAR-Research (Ham- Classon for assistance with the sequence comparisons. This work
was supported by the Arthritis Research Campaign, the Biotechnol-burg, Germany) image plate detector. The diffraction data were
processed and scaled with the HKL program suite (Otwinowski and ogy and Biological Sciences Research Council, the Engineering and
Physical Sciences Research Council, the Medical Research Council,Minor, 1997; statistics reported in Table 1). The expected six Se
atom positions were determined, refined, and phases calculated to the Royal Society and the Wellcome Trust. S. I. and D. I. S. are
members of the Tsukuba Advanced Research Alliance project of3.0 AÊ resolution, using the program SOLVE (Terwilliger and Berend-
zen, 1997). An initial electron density map based on these phases Tsukuba University, Tsukuba, Japan. The analytical ultracentrifuga-
tion experiments were performed in the AUC facility established bywas improved with programs DM and SOLOMON (CCP4, 1994) to
yield a high quality electron density map. The structure was built the BBSRC and the Wellcome Trust in the Glycobiology Institute of
the University of Oxford. The facility is managed by Dr. Russellusing program O (Jones et al., 1991). The entire course of the main
chain was apparent; however, only half the true side chains were Wallis.
built, with the remainder initially modeled as alanines.
Refinement with CNS (Brunger et al., 1998) used a set of Fobs
Received November 2, 1999; revised December 16, 1999.constructed by merging the diffraction data (including Bjivoet pairs)
from all three MAD wavelengths. After some refinement and manual
rebuilding, the entire sB7-1 sequence was fitted and clear electron
Referencesdensity allowed the unambiguous positioning of three N-linked
N-acetylglucosamine residues. Further refinement of the atomic po-
Aruffo, A., and Seed, B. (1987). Molecular cloning of a CD28 cDNAsitions and tightly restrained individual isotropic B-factors resulted
by a high-efficiency COS cell expression system. Proc. Natl. Acad.in a final crystallographic Rfactor and Rfree of 23.7% and 28.2%, respec- Sci. USA 84, 8573±8577.tively. In the final model, 80.4% of residues fall in the most favored
Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J.H., Lanier,regions of the Ramachandran plot and no nonglycine residues fall
L.L., and Somoza, C. (1993). B70 antigen is a second ligand forin disallowed regions (Laskowski et al., 1993). Refinement and model
CTLA-4 and CD28. Nature 366, 76±79.statistics are reported in Table 1.
Structural superpositions used program SHP (Stuart et al., 1979). Bajorath, J., Peach, R.J., and Linsley, P.S. (1994). Immunoglobulin
fold characteristics of B7-1 (CD80) and B7-2 (CD86). Protein Sci. 3,Figures 1±3, 6, 7, and 9 were produced using programs BOBSCRIPT
(Esnouf, 1997) and Raster3D (Merritt and Murphy, 1994). Electro- 2148±2150.
static analysis and surface display for Figures 5 and 7 used the Barclay, A.N., Brown, M.H., Law, S.K.A., McKnight, A.J., Tomlinson,
program GRASP (Nicholls et al., 1991). M.G., and van der Merwe, P.A. (1997). The Leukocyte Antigen Facts-
book (London: Academic Press).
Analytical Ultracentrifugation Methods Bodian, D.L., Jones, E.Y., Harlos, K., Stuart, D.I., and Davis, S.J.
Analytical ultracentrifugation used a Beckman Instruments Optima (1994). Crystal structure of the extracellular region of the human cell
XL-A equipped with scanning absorbance optics utilizing wave- adhesion molecule CD2 at 2.5 AÊ resolution. Structure 15, 755±766.
lengths of 225 nm, 230 nm, 254 nm, 280 nm, 300 nm, 310 nm, and
Borriello, F., Sethna, M.P., Boyd, S.D., Schweitzer, A.N., Tivol, E.A.,320 nm, depending on the protein concentrations present (Tuma
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A.H. (1997). B7-1 and B7-2 have overlapping, critical roles in immu-reached when distribution scans acquired 3 hr apart were coinci-
noglobulin class switching and germinal center formation. Immunitydent. The experiments were performed at a rotor speed of 10,000
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patterns of interacting proteins and the sedimentation behavior of
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(n 2 1)M1c
Kd 1 c
1 M1 (2)
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Davis, S.J., and van der Merwe, P.A. (1996). The structure and ligandwhere Mw,app is the apparent whole-cell weight-average molecular
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